Sign Up to like & get
recommendations!
1
Published in 2018 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.664
Abstract: Natalizumab blocks α4‐integrin‐mediated leukocyte migration into the central nervous system (CNS). It diminishes disease activity in multiple sclerosis (MS), but carries a high risk of progressive multifocal encephalopathy (PML), an opportunistic infection with JV virus…
read more here.
Keywords:
tlr3 agonism;
cns immune;
immune competence;
integrin deficiency ... See more keywords